EG Life Sciences

EG Life Sciences, a company of Eliassen Group, is a professional services firm that provides scalable consulting and talent solutions to the pharmaceutical, biotechnology, and medical device industries. The company specializes in quality, regulatory and compliance, validation, engineering, project management, and biometrics. Following the 2021 acquisition of The Evanston Group, EG Life Sciences expanded its capabilities to include high-level subject matter expertise across the product development lifecycle, from R&D to commercialization. They support clients in navigating complex FDA regulations and submissions through various engagement models, including interim leadership and project-based solutions.